You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced pancreatic adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Locally Advanced Pancreatic Adenocarcinoma Trial in Houston (SD-101, pebrolizumab)

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Nov 18, 2022

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Aug 8, 2022

Locally Advanced Pancreatic Cancer Trial (FOLFIRINOX chemo, OncoSil™)

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • FOLFIRINOX chemotherapy
  • OncoSil™
  • (no location specified)
Jul 18, 2022

Survival, Quality of Life and Resectability in Locally Advanced

Recruiting
  • Pancreas Cancer
  • +8 more
    • Umeå, Sweden
      Surgical Clinic at Umeå University Hospital
    Nov 23, 2022

    Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable

    Not yet recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +8 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 9, 2023

    Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Pancreatic Cancer Non-resectable
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 24, 2022

    Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body

    Not yet recruiting
    • Pancreas Cancer
    • +2 more
    • Stereotactic Ablative Body Radiation (SABR)
    • Tumor Treating Fields (TTF)
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Dec 27, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Enfortumab vedotin
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Jun 23, 2023

    Locally Advanced Unresectable Pancreatic Adenocarcinoma Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

    Not yet recruiting
    • Locally Advanced Unresectable Pancreatic Adenocarcinoma
    • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
    • (no location specified)
    Jun 25, 2023

    Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

    Not yet recruiting
    • Pancreatic Cancer
    • +2 more
    • DaRT seeds insertion
    • (no location specified)
    Sep 5, 2023

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

    Not yet recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • Biospecimen Collection
    • +9 more
    • Los Angeles, California
      Yonemoto,Lisa
    Jan 13, 2023

    Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Charlottesville (EGFR BATs after

    Recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • Metastatic Pancreatic Adenocarcinoma
    • EGFR BATs after standard of care chemo
    • Charlottesville, Virginia
      University of Virginia
    Mar 30, 2022

    Pancreatic Ductal Adenocarcinoma Trial in United States (NALIRIFOX, AD-XRT and Capecitabine)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Basking Ridge, New Jersey
    • +6 more
    May 15, 2023

    Surgery After Neoadjuvant Chemotherapy in Locally Advanced

    Completed
    • Postoperative Complications
    • surgery after neoadjuvant chemotherapy
    • Seoul, Korea, Republic of
      Asan medical center
    Jun 1, 2023

    Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

    Recruiting
    • Untreated Resectable Pancreatic Adenocarcinoma
    • +2 more
    • Paclitaxel protein bound
    • +3 more
    • Scottsdale, Arizona
      HonorHealth Research Institute
    May 10, 2022

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • (no location specified)
    Sep 23, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

    Completed
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +6 more
    • Houston, Texas
    • +4 more
    Aug 31, 2022

    Pancreas Adenocarcinoma Trial in Pennington (Cyberknife)

    Recruiting
    • Pancreas Adenocarcinoma
    • Cyberknife
    • Pennington, New Jersey
      Capital Health Medical Center-Hopewell
    Aug 30, 2021

    Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

    Not yet recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +6 more
    • Biopsy
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Apr 26, 2022

    Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

    Not yet recruiting
    • Gastric Cancer
    • +3 more
    • LB1908
    • (no location specified)
    Sep 9, 2022

    Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

    Active, not recruiting
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Aug 3, 2022

    Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma Trial in Shanghai (Nab paclitaxel plus

    Recruiting
    • Borderline Resectable Pancreatic Cancer
    • Locally Advanced Pancreatic Adenocarcinoma
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Jan 27, 2022

    Locally Advanced Pancreatic Adenocarcinoma Trial in Guangzhou (Irreversible electroporation, Gemcitabine)

    Completed
    • Locally Advanced Pancreatic Adenocarcinoma
    • Guangzhou, Guangdong, China
      Institutional Review Board of Guangzhou FUDA Cancer Hospital
    Sep 1, 2021